A Study in Participants With Moderate to Severe Psoriasis (UNCOVER-3)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
This study will assess the safety and efficacy of ixekizumab (LY2439821), compared to etanercept and placebo in participants with moderate to severe chronic plaque psoriasis.
Epistemonikos ID: 0401d2bba47f0bd1ad0bdee38451397cdd96881d
First added on: May 22, 2017